From an Idea to a Journey: My Path Toward Treating Gout and Hyperuricemia With Cyclodextrins
When I look back at the last few years, it’s hard not to feel moved by what this project has
Tag: CD as active
An unprecedented example for sole cyclodextrins as API: an ophthalmic composition with hydroxypropyl betadex, alone
A paradigm shift in cyclodextrin technology started with the design, development and marketing of Sugammadex®/Bridion®, and followed by designation of
Folate-appended CDs in cancer therapy
The team of Motoyama in Kumamoto has recently published new results on folate-appended CDs in leukemia and ovarian cancer (1,2).
Twenty years of research on cyclodextrin conjugates with PAMAM dendrimers
Cyclodextrin (CD) conjugates with starburst polyamidoamine (PAMAM) dendrimer (CDEs), as a new type of polymer-based carriers, were first published in
Meet the Experts: Cyclodextrins as active ingredients in the 21st century – Webinar of CycloLab
After the great success of the webinar held in May, 2021 a next webinar organized by CycloLab will be held
Meet the Experts: Applications of Cyclodextrins in the Pharma Industries
A webinar organized by CycloLab will be held on April 15-16, 2021. Participation at the event is provided free of charge
CycloLab at BIO Digital
As the readers of Cyclodextrin News have been already informed, 2020 BIO International Convention will be a digital event to